Sudden cardiac death in patients with chronic coronary heart disease

J L Hurwitz1, M E Josephson

  • 1Clinical Electrophysiology Laboratory, Hospital of the University of Pennsylvania, Philadelphia 19104.

Circulation
|January 1, 1992
PubMed

Insights

Sudden cardiac death (SCD) affects 300,000-400,000 annually. Identifying inducible ventricular tachycardia via electrophysiological study is key for managing SCD recurrence risk.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Sudden Cardiac Death Research

Background:

  • Sudden cardiac death (SCD) causes 300,000-400,000 deaths yearly, with a 40% recurrence rate in survivors within 2 years.
  • Coronary artery disease, particularly with left ventricular dysfunction, is a primary risk factor, though SCD can be the initial presentation.
  • Ventricular tachycardia is the most common arrhythmic cause of SCD, often linked to slowed conduction in damaged ventricles.

Purpose of the Study:

  • To investigate the predictors and management strategies for sudden cardiac death (SCD) and its recurrence.
  • To evaluate the role of electrophysiological studies in identifying patients at risk for SCD.
  • To assess the effectiveness of pharmacological and surgical interventions in preventing SCD recurrence.

Main Methods:

  • Analysis of endocardial mapping during electrophysiological studies in SCD patients.
  • Assessment of left ventricular function and signal-averaged electrocardiograms as predictors.
  • Evaluation of inducible ventricular tachycardia and patient response to antiarrhythmic drugs or interventions.

Main Results:

  • Poor left ventricular function is a better predictor of SCD recurrence than complex ventricular ectopy.
  • Electrophysiological studies reveal slowed conduction in SCD patients with ventricular damage.
  • Pharmacological rendering of noninducible ventricular tachycardia improves prognosis; persistent inducibility or non-inducibility indicates high recurrence risk.

Conclusions:

  • Electrophysiological study is crucial for risk stratification in sudden cardiac death (SCD).
  • Patients with inducible ventricular tachycardia who become noninducible with medication have a favorable prognosis.
  • High-risk patients may benefit from subendocardial resection or implantable defibrillators to prevent SCD recurrence.

Related Concept Videos

Disturbances in Heart Rhythm01:29

Disturbances in Heart Rhythm

Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Introduction Cardiac Emergencies01:30

Introduction Cardiac Emergencies

Cardiac emergencies are critical situations involving the heart that require immediate medical intervention to prevent severe complications or death. These emergencies often arise from underlying heart conditions that impair the heart's ability to function correctly.Types of Cardiac EmergenciesThe most common types of cardiac emergencies include Acute Coronary Syndrome (ACS), myocardial infarction (MI), cardiac arrest, and heart failure.Acute Coronary Syndrome (ACS)Acute Coronary Syndrome (ACS)...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...